Fisher A - Search Results

1

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.

Fisher A, Brandeis R, Haring R, Eshhar N, Heldman E, Karton Y, Eisenberg O, Meshulam H, Marciano D, Bar-Ner N, Pittel Z. Fisher A, et al. J Physiol Paris. 1998 Oct-Dec;92(5-6):337-40. doi: 10.1016/S0928-4257(99)80001-1. J Physiol Paris. 1998. PMID: 9789833 Review.

2

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.

Fisher A, Brandeis R, Bar-Ner RH, Kliger-Spatz M, Natan N, Sonego H, Marcovitch I, Pittel Z. Fisher A, et al. J Mol Neurosci. 2002 Aug-Oct;19(1-2):145-53. doi: 10.1007/s12031-002-0025-3. J Mol Neurosci. 2002. PMID: 12212772

3

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R. Fisher A, et al. J Mol Neurosci. 2003;20(3):349-56. doi: 10.1385/JMN:20:3:349. J Mol Neurosci. 2003. PMID: 14501019 Review.

4

(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E. Fisher A, et al. J Pharmacol Exp Ther. 1991 Apr;257(1):392-403. J Pharmacol Exp Ther. 1991. PMID: 2019998

5

Selective signaling via unique M1 muscarinic agonists.

Fisher A, Heldman E, Gurwitz D, Haring R, Barak D, Meshulam H, Marciano D, Brandeis R, Pittel Z, Segal M, et al. Fisher A, et al. Ann N Y Acad Sci. 1993 Sep 24;695:300-3. doi: 10.1111/j.1749-6632.1993.tb23070.x. Ann N Y Acad Sci. 1993. PMID: 8239299 Review.

6

Progress in medicinal chemistry of novel selective muscarinic agonists.

Fisher A, Karton Y, Heldman E, Gurwitz D, Haring R, Meshulam H, Brandeis R, Pittel Z, Segall Y, Marciano D, et al. Fisher A, et al. Drug Des Discov. 1993;9(3-4):221-35. Drug Des Discov. 1993. PMID: 8400004 Review.

7

Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells.

Danenberg HD, Haring R, Heldman E, Gurwitz D, Ben-Nathan D, Pittel Z, Zuckerman A, Fisher A. Danenberg HD, et al. Among authors: fisher a. Ann N Y Acad Sci. 1995 Dec 29;774:300-3. doi: 10.1111/j.1749-6632.1995.tb17392.x-i1. Ann N Y Acad Sci. 1995. PMID: 8597471

8

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.

Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD. Fisher A, et al. Ann N Y Acad Sci. 1996 Jan 17;777:189-96. doi: 10.1111/j.1749-6632.1996.tb34418.x. Ann N Y Acad Sci. 1996. PMID: 8624083 Review.

9

Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein.

Danenberg HD, Haring R, Fisher A, Pittel Z, Gurwitz D, Heldman E. Danenberg HD, et al. Among authors: fisher a. Life Sci. 1996;59(19):1651-7. doi: 10.1016/0024-3205(96)00496-1. Life Sci. 1996. PMID: 8913330

10

Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum.

Pittel Z, Heldman E, Barg J, Haring R, Fisher A. Pittel Z, et al. Among authors: fisher a. Brain Res. 1996 Dec 2;742(1-2):299-304. doi: 10.1016/s0006-8993(96)01031-1. Brain Res. 1996. PMID: 9117408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,207 results

Search Page

Filters